Peter A. Campochiaro
Impact in
- Ophthalmology top 0.01%
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Glaucoma and retinal disorders
- Ocular Diseases and Behçet’s Syndrome
- Radiology, Nuclear Medicine and Imaging top 0.02%
- Retinal Imaging and Analysis
- Retinal and Macular Surgery
Papers in
- Ophthalmology 295
- Retinal Diseases and Treatments 261
- Retinal and Optic Conditions 70
- Glaucoma and retinal disorders 65
- Ocular Diseases and Behçet’s Syndrome 23
-
- Retinal Development and Disorders 145
- Angiogenesis and VEGF in Cancer 36
- Co-authors
- Sean F. Hackett (44 shared papers)Roman G. Rubio (10 shared papers)Donald J. Zack (41 shared papers)Sean F. Hackett (37 shared papers)Namrata Saroj (5 shared papers)Bert M. Glaser (10 shared papers)David M. Brown (12 shared papers)Stanley A. Vinores (32 shared papers)
- Journals
- Investigative Ophthalmology & Visual Science (48 papers)Ophthalmology (36 papers)Journal of Cellular Physiology (31 papers)American Journal of Ophthalmology (17 papers)Experimental Eye Research (16 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Peter A. Campochiaro
375 papers receiving 28.0k citations
Peter A. Campochiaro's Hit Papers
Peers
Comparison fields: 5 of 155
- Ophthalmology 19.2k
- Radiology, Nuclear Medicine and Imaging 11.4k
- Molecular Biology 13.4k
- Neurology 1.1k
- Cancer Research 1.8k
Countries citing papers authored by Peter A. Campochiaro
This map shows the geographic impact of Peter A. Campochiaro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Campochiaro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Campochiaro more than expected).
Fields of papers citing papers by Peter A. Campochiaro
This network shows the impact of papers produced by Peter A. Campochiaro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Campochiaro. The network helps show where Peter A. Campochiaro may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Campochiaro, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 382 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Ranibizumab for Macular Edema following Central Retinal Vein Occlusion Hit paper breakdown → | 2010 | 926 |
| 2 | Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1 Hit paper breakdown → | 2002 | 785 |
| 3 | Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Hit paper breakdown → | 2010 | 634 |
| 4 | Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study Hit paper breakdown → | 2011 | 575 |
| 5 | Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 Hit paper breakdown → | 2003 | 512 |
| 6 | Molecular pathogenesis of retinal and choroidal vascular diseases Hit paper breakdown → | 2015 | 408 |
| 7 | Sustained Benefits from Ranibizumab for Macular Edema Following Branch Retinal Vein Occlusion: 12-Month Outcomes of a Phase III Study Hit paper breakdown → | 2011 | 376 |
| 8 | Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema Hit paper breakdown → | 2012 | 376 |
| 9 | Ranibizumab for Macular Edema Due to Retinal Vein Occlusions Hit paper breakdown → | 2012 | 373 |
| 10 | 2006 | 356 | |
| 11 | 2000 | 317 | |
| 12 | Ocular neovascularization Hit paper breakdown → | 2013 | 315 |
| 13 | 1998 | 315 | |
| 14 | Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion Hit paper breakdown → | 2014 | 310 |
| 15 | 2011 | 288 | |
| 16 | Hypoxia inducible factor-1alpha is increased in ischemic retina: temporal and spatial correlation with VEGF expression. | 1999 | 283 |
| 17 | 2001 | 274 | |
| 18 | 2008 | 266 | |
| 19 | 2006 | 265 | |
| 20 | 2009 | 264 |
About Peter A. Campochiaro
Peter A. Campochiaro is a scholar working on Ophthalmology, Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Neurology, having authored 382 papers that have together received 28.9k indexed citations. Recurring topics across this work include Retinal Diseases and Treatments (261 papers), Retinal Development and Disorders (145 papers), Retinal and Optic Conditions (70 papers), Glaucoma and retinal disorders (65 papers), Retinal Imaging and Analysis (60 papers), Retinal and Macular Surgery (58 papers), Angiogenesis and VEGF in Cancer (36 papers) and Ocular Diseases and Behçet’s Syndrome (23 papers). The work is most often cited by research in Ophthalmology (19.2k citations), Radiology, Nuclear Medicine and Imaging (11.4k citations), Molecular Biology (13.4k citations), Neurology (1.1k citations) and Cancer Research (1.8k citations). Peter A. Campochiaro has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Sean F. Hackett, Roman G. Rubio, Donald J. Zack, Sean F. Hackett, Namrata Saroj, Bert M. Glaser, David M. Brown, Stanley A. Vinores, Sarah Gray and Wendy Yee Murahashi. Their work appears in journals such as Investigative Ophthalmology & Visual Science, Ophthalmology, Journal of Cellular Physiology, American Journal of Ophthalmology and Experimental Eye Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.